Evidence map›Paper›PMID 34093028›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2021

Lipid Accumulation Product is Associated with Urinary Albumin-creatinine Ratio in Chinese Prediabitic Population: A Report from the REACTION Study.

Yang Liu, Yun Wang, Jie Wang, Kang Chen, Lingzi Jin, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan and 4 more

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Yang Liu *Graduate School, Chinese PLA General Hospital, Beijing, People's Republic of China.
Yun Wang *Graduate School, Chinese PLA General Hospital, Beijing, People's Republic of China.
Jie WangDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.ORCID 0000-0003-4706-0302
Kang ChenDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
Lingzi JinDepartment of International Medical Services, Peking Union Medical College Hospital (Xidan Campus), Beijing, People's Republic of China.
Weiqing WangShanghai National Research Centre for Endocrine and Metabolic Diseases, State Key Laboratory of Medical Genomics, Shanghai Institute for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
Zhengnan GaoDepartment of Endocrinology, Dalian Central Hospital, Dalian, Liaoning, People's Republic of China.
Xulei TangDepartment of Endocrinology, First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Li YanDepartment of Endocrinology, Zhongshan University Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, People's Republic of China.
Qin WanDepartment of Endocrinology, Southwest Medical University Affiliated Hospital, Luzhou, Sichuan, People's Republic of China.
Zuojie LuoDepartment of Endocrinology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Guijun QinDepartment of Endocrinology, First Affiliated Hospital of Zhengzhou University, Zhenzhou, Henan, People's Republic of China.
Lulu ChenDepartment of Endocrinology, Wuhan Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Yiming MuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.ORCID 0000-0002-3344-3540
Chinese PLA General Hospital · CNAffiliated Hospital of Southwest Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNDalian Municipal Central Hospital · CNFirst Affiliated Hospital of Zhengzhou University · CNFirst Hospital of Lanzhou University · CNGuangxi Medical University · CNRuijin Hospital · CNSun Yat-sen University · CNWuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLipid accumulation product (LAP) as a powerful marker of visceral obesity is an independent risk factor of chronic kidney disease. The present study attempted to explore the association between LAP and albuminuria in prediabetic individuals.

methodsWe conducted a cross-sectional study and enrolled 26,529 participants with prediabetes over 40 years old with prediabetes from seven provinces in China. LAP was calculated from waist circumference and fasting triglycerides. Elevated albuminuria was defined by urinary albumin-creatinine ratio (uACR) ≥30 mg/g. Propensity score matching was applied to reduce bias, comparison between LAP and other traditional visceral obesity indices was performed and multiple logistic regression models were conducted to assess the association between LAP and albuminuria in the prediabetic population.

resultsIndividuals with uACR ≥30 mg/g were older and had higher BP, BMI, WC, TG, fasting insulin, glycohemoglobin and LAP, as well as lower eGFR and HDL level. Multiple logistic regression analysis showed elevated LAP was associated with increased odds of albuminuria (OR [95%CI]

conclusionElevated level of LAP was associated with increased albuminuria in the prediabetic population in China.

Indexed as

albuminurialipid accumulation productprediabetesvisceral obesity

Identifiers

PMID34093028
PMCPMC8168967
OpenAlexW3165749082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.